İbrahim Barışta

5PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.

|Jul 12, 2025
Machine learning-based risk prediction model for central nervous system involvement in diffuse large B-cell lymphoma.

Rashad Ismayilov, Murat Ozdede, Aysegul Uner

|Jun 26, 2025
Impact of Time-to-Treatment Initiation and First Inter-Cycle Delay in Patients with Hodgkin Lymphoma.

Deniz Donmez, Yasemin Evlendi, Taha Koray Sahin

|Mar 17, 2025
Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer.

Onur Baş, Naciye Güdük, Mert Tokatlı

|Dec 06, 2023
Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management.

Arif Akyildiz, Rashad Ismayilov, Nargiz Rustamova

Pageof 1

Frequent Collaborators

3 joint publications

Serkan Akın

2 joint publications

Rashad Ismayilov

2 joint publications

Mert Tokatlı

1 joint publications

Arif Akyildiz